Sort
38,696 grants matching “als”
Libby Epidemiology Research Program
$965,000Raja M Flores · Icahn School Of Medicine At Mount Sinai · R01 · FY2012 · TS
Libby Epidemiology Research Program
$965,000Jaime Szeinuk · Icahn School Of Medicine At Mount Sinai · R01 · FY2011 · TS
Libby Epidemiology Research Program
$965,000Raja M. Flores · Icahn School Of Medicine At Mount Sinai · R01 · FY2013 · TS
Mechanisms of Alcoholic Liver Disease
$964,607Bin Gao · National Institute On Alcohol Abuse And Alcoholism · Z01 · FY2008 · AA
The Laboratory of Stem Cell Biology
$964,085Mahendra Rao · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2013 · AR
VALIDATION OF SYF2 SUPPRESSION AS A THERAPEUTIC STRATEGY FOR DIVERSE FORMS OF ALS
$963,753University Of Southern California · · FY2021 · Defense Health Agency
Conformational Changes in Glutamate transporters
$963,354Joseph A Mindell · National Institute Of Neurological Disorders And Stroke · ZIA · FY2010 · NS
Symptom Distress Mechanisms in Digestive Disorders
$963,315Wendy Henderson · National Institute Of Nursing Research · ZIA · FY2017 · NR
Identifying Neural Substrates of Behavior in Drosophila Melanogaster
$963,207Benjamin H White · National Institute Of Mental Health · ZIA · FY2009 · MH
Structure and Function of Membrane Proteins
$962,837Miguel Holmgren · National Institute Of Neurological Disorders And Stroke · ZIA · FY2017 · NS
ROBUST SUBTYPE MARKERS FOR ALS PATIENT STRATIFICATION
$962,713Arizona State University · · FY2025 · Defense Health Agency
Mechanistic and translational studies of CBF leukemia
$961,667Paul Liu · National Human Genome Research Institute · ZIA · FY2015 · HG
Systems-level analysis of the regulation and function of p53 dynamics
$961,569Eric Batchelor · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Characterization and Regulation of High Risk and Malignant Breast Epithelium
$961,249David Danforth · Clinical Sciences · Z01 · FY2007 · CA
MATRIX METALLOPROTEINASE INHIBITOR FOR THE TREATMENT OF ALS
$961,150Aquilus Pharmaceuticals, Inc. · · FY2022 · Defense Health Agency
RNA-binding Factors Implicated in Neurogenesis, Alzheimer's Disease, and other Neurodegenerative Pathologies
$961,086Myriam Gorospe · National Institute On Aging · ZIA · FY2023 · AG
Synaptic mechanims underlying reward seeking and comupulsive drug use
$960,850Veronica A Alvarez · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2012 · AA
Treatment of Glioblastoma: the combination of fluorescence guided surgery and photodynamic therapy
$960,821William R Potter · Photolitec, Llc · R44 · FY2022 · CA
Exploring Cognitive Aging Using Reference Ability Neural Networks
$960,772Yaakov Stern · Columbia University Health Sciences · R01 · FY2014 · AG
Monitoring real-world driver behavior for classification and early prediction of Alzheimerâs disease
$960,603Matthew Rizzo · University Of Nebraska Medical Center · R01 · FY2024 · AG
Exploring Cognitive Aging Using Reference Ability Neural Networks
$960,515Yaakov Stern · Columbia University Health Sciences · R01 · FY2012 · AG
Biostatistics for Research in Environmental Health
$960,409Amy H Herring · Univ Of North Carolina Chapel Hill · T32 · FY2012 · ES
Riluzole Prodrugs for Melanoma and ALS
$960,120Allen Bernard Reitz · Fox Chase Chemical Diversity Center, Inc · R44 · FY2013 · CA
Stem Cell Therapy and Growth Factor Therapy for ALS
$960,075Clive Niels Svendsen · Cedars-Sinai Medical Center · P01 · FY2011 · NS
Riluzole Prodrugs for Melanoma and ALS
$959,604Allen Bernard Reitz · Fox Chase Chemical Diversity Center, Inc · R44 · FY2014 · CA